Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tranexamic Acid vs Glutathione Mesotherapy in Post Burn Facial Hyperpigmentation
NCT07263841Phase 2Active, not recruiting
- Sponsor
- King Edward Medical University
- Start
- Jun 2025
- Primary completion
- Dec 2025
- Modality
- Peptides, Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tranexamic acid, glutathione in Post-inflammatory hyperpigmentation (PIH), sponsored by King Edward Medical University. Started Jun 2025; status: active, not recruiting.
02
Drugs
tranexamic acidglutathione
03
Conditions
Post-inflammatory hyperpigmentation (PIH)
Beyond the preview
Go deeper on NCT07263841.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07263841.